Bicalutamide 比卡鲁胺
Bicalutamide 是一种具有口服活性的非甾体雄激素受体 (AR) 拮抗剂。Bicalutamide 可用于前列腺癌的研究。
-
货号:
TK0620 -
规格:
- 10mg
- 25mg
- 50mg
- 100mg
- 200mg
-
价格:
¥0.00
Bicalutamide 是一种具有口服活性的非甾体雄激素受体 (AR) 拮抗剂。Bicalutamide 可用于前列腺癌的研究。
| CAS No. | 90357-06-5 |
| 生物活性 | Bicalutamide is an orally active non-steroidal androgen receptor (AR) antagonist. Bicalutamide can be used for the research of prostate cancer. |
| 分子式 | C18H14F4N2O4S |
| 分子量 | 430.37 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder -20°C 3 years |
| 溶解性数据 | DMSO : ≥ 50 mg/mL (116.18 mM) |
| 体内研究 | Bicalutamide (10 mg/kg; i.g.; daily; for 28 days) exhibits anti-tumor activity in prostate cancer mice model. |
| 体外研究 | Bicalutamide competes with androgens for binding AR in in a whole-cell binding-assay (LNCaP/AR(cs) cells), with an IC50 of 160 nM. Bicalutamide induces proliferation of VCaP cells in a dose-dependent manner, whereas partially antagonizes the effects of R1881 (synthetic androgen). |
| 文献 | •Cell Death Dis. 2021 Jul 27;12(8):740. •Sci Rep. 2017 Jun 8;7(1):3058. •J Drug Deliv Sci Technol. 2021, 102340. •EJNMMI Res. 2018 Oct 29;8(1):96. •Research Square Preprint. 2020 Nov 4;rs.3.rs-100914. •RNA & Disease. 2020 Apr. •Royal Society of Chemistry. 2020,10, 10254-10262. |
| 纯度及产品资料 | 98% |